Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-24T18:37:46.782Z Has data issue: false hasContentIssue false
  • English
  • Français

Cholesterol Lowering, Nutrition and Stroke Prevention

Published online by Cambridge University Press:  02 December 2014

J. David Spence
J. David Spence*
Affiliation:
Western University London, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 39 , Issue 6 , November 2012 , pp. 700 - 701
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1. Kim, H-J, Kim, E-K, Kwon, SU, Kim, JS, Kang, D-W. Effect of statin on progression of symptomatic intracranial atherosclerosis. Can J Neurol Sci. 2012;39(6):801–6.CrossRefGoogle ScholarPubMed
2. Kim, DE, Kim, JY, Jeong, SW, et al. Association between changes in lipid profiles and progression of symptomatic intracranial atherosclerotic stenosis: a prospective multicenter study. Stroke. 2012;43:1824–30.CrossRefGoogle ScholarPubMed
3. Chimowitz, MI, Lynn, MJ, Howlett-Smith, H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–16.CrossRefGoogle ScholarPubMed
4. Kasner, SE, Lynn, MJ, Chimowitz, MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006;67:1275–8.CrossRefGoogle ScholarPubMed
5. Chimowitz, MI, Lynn, MJ, Derdeyn, CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003.CrossRefGoogle ScholarPubMed
6. Nilanont, Y, Poungvarin, N. Management and prevention of intracranial atherosclerotic disease. In: Spence, JD, Barnett, HJ, editors. Stroke prevention, treatment and rehabilitation. New York: McGraw-Hill Medical; 2012. p. 139–51.Google Scholar
7. Kim, DE, Lee, KB, Jang, IM, Roh, H, Ahn, MY, Lee, J. Associations of cigarette smoking with intracranial atherosclerosis in the patients with acute ischemic stroke. Clin Neurol Neurosurg. 2012 Mar 23; Epub ahead of print.CrossRefGoogle Scholar
8. Wong, KS, Chen, C, Fu, J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9:489–97.CrossRefGoogle ScholarPubMed
9. Kwon, SU, Hong, KS, Kang, DW, et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke. 2011;42:2883–90.CrossRefGoogle ScholarPubMed
10. Amarenco, P, Labreuche, J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8:453–63.CrossRefGoogle ScholarPubMed
11. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Eng J Med. 2006;355: 549–59.CrossRefGoogle Scholar
12. Sillisen, H, Amarenco, P, Hennerici, MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial. Stroke. 2008;39:3297–302.CrossRefGoogle Scholar
13. Spence, JD. Lipid lowering therapy. In: Spence, JD, Barnett, HJ, editors. Stroke prevention, treatment and rehabilitation. New York: McGraw-Hill Medical; 2012. p. 131–8.Google Scholar
14. Spence, JD, Hackam, DG. Treating arteries instead of risk factors. A paradigm change in management of atherosclerosis. Stroke. 2010;41:1193–9.CrossRefGoogle ScholarPubMed
15. Spence, JD, Coates, V, Li, H, et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010;67:180–6.CrossRefGoogle Scholar
16. Spence, JD, Tamayo, A, Lownie, SP, Ng, WP, Ferguson, GG. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke. 2005;36:2373–8.CrossRefGoogle ScholarPubMed
17. Markus, HS, King, A, Shipley, M, et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 2010;9:663–71.CrossRefGoogle ScholarPubMed
18. Sattar, N, Preiss, D, Murray, HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375:735–42.CrossRefGoogle ScholarPubMed
19. Spence, JD. Carotid plaque measurement is superior to IMT. Invited editorial comment on: carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Inaby, Y, Chen, JA, Bergmann, SR. Atherosclerosis. 2011;220:34–5.Google Scholar
20. Bogiatzi, C, Spence, JD. Ezetimibe and regression of carotid atherosclerosis: importance of measuring plaque burden. Stroke. 2012;43:1153–5.CrossRefGoogle ScholarPubMed
21. Spence, JD. Secondary stroke prevention. Nat Rev Neurol. 2010;6:477–86.CrossRefGoogle ScholarPubMed
22. Spence, JD. How to prevent your stroke. Nashville: Vanderbilt University Press; 2006.Google Scholar
23. Spence, JD. Nutrition, diabetes and stroke prevention. In: Spence, JD, Barnett, HJ, editors. Stroke prevention, treatment and rehabilitation. New York: McGraw-Hill Medical; 2012. p. 40–9.Google Scholar
24. Renaud, S, de Lorgeril, M, Delaye, J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995; 61:1360S–7S.CrossRefGoogle ScholarPubMed
25. Shai, I, Schwarzfuchs, D, Henkin, Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359:229–41.CrossRefGoogle ScholarPubMed
26. Spence, JD, Jenkins, DJ, Davignon, J. Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Can J Cardiol. 2010;26:e336–e339.CrossRefGoogle Scholar
27. Spence, JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;7:830–8.CrossRefGoogle Scholar
28. Spence, JD, Stampfer, MJ. Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses. JAMA. 2011;306(23):2610–11.CrossRefGoogle ScholarPubMed